Probing dimension-8 SMEFT operators through neutral meson mixing
Yi Liao (South China Normal U.), Xiao-Dong Ma (South China Normal U.),, Hao-Lin Wang (South China Normal U.)

TL;DR
This paper explores how dimension-8 operators in SMEFT influence neutral meson mixing, providing constraints on their scales and presenting a UV model where these operators dominate, thus offering new insights into potential new physics.
Contribution
It analyzes the impact of dimension-8 SMEFT operators on meson mixing and establishes constraints on their scales, highlighting scenarios where dim-8 operators are leading in UV models.
Findings
Neutral meson mixing probes operators up to 80 TeV scale.
Dimension-8 operators can dominate in certain UV models.
Constraints surpass those from other observables for some operators.
Abstract
We investigate the impact of effective interactions of dimension-8 (dim-8) operators in the standard model effective field theory (SMEFT) on neutral meson mixing, focusing on the , , and systems. Within the framework of the low energy effective field theory (LEFT), each system is governed by eight dim-6 operators, with four originating at tree level from dim-6 SMEFT operators and the other four from dim-8 SMEFT operators. Notably, in certain UV complete models those dim-8 operators instead of the dim-6 ones are generated at the leading order. Our analysis focuses on those dim-8 operators and includes their one-loop QCD renormalization group running effects. By leveraging the LEFT master formula we impose stringent constraints on the effective scales associated with these dim-8 operators. We find that neutral meson mixing can probe an…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMedical Imaging Techniques and Applications · Gastrointestinal Tumor Research and Treatment · Neuroendocrine Tumor Research Advances
